Search

Permanent (CDI) bioinformatics engineer position in the Microbiome Studio business unit of Abolis Biotechnologies in Paris 13, which develops a solution to understand the metabolic pathways of microorganisms for nutrition, health, cosmetics

Phage Consultants CEO Marcin Łoś was at PHI Korea in Seoul for the first time, meeting Asian clients and potential partners and presenting the company’s portfolio, including swab sampling and virulent phage testing. Phage Consultants

Pauliina Lajunen joined PrecisionPhage as Chief Business Officer in August 2026. PrecisionPhage

Cytophage announced that Will Ollerhead resigned as a director effective April 29, 2026. Cytophage Technologies Ltd.

Cytophage announced that Chief Operating Officer Heather Medwick left the company effective March 31, 2026, as part of its corporate restructuring. Cytophage Technologies Ltd.

Cytophage formed a committee of independent and disinterested directors to evaluate strategic alternatives, including unsolicited strategic financing proposals. The board had not set a timetable or made a decision on a potential transaction

Phagos (Suresnes, France) offered a six-month AI research internship, planned to start 1 February 2026, exploring how large AI models can predict bacteriophage–host interactions using real biological datasets. Candidates should be enrolled

Phagos (Suresnes, France) sought a Research Scientist, Phage Evolution on a permanent contract (€50K–60K) to lead phage training and directed evolution: designing experiments that improve host range, lytic activity and resistance to bacteri

Phagos advertised a permanent laboratory technician role in microbiology in Suresnes, France, on its Lab Ops team, applying phage therapy techniques to animal farming. The technician runs routine microbiological tests, cultures bacteria, is

Phagos (Suresnes, France) hired a Bioinformatics Engineer on a permanent contract (€50K–60K, planned start 26 January 2026) to build Nextflow pipelines for high-throughput structural genomics, clustering phage receptor-binding proteins and

Phagos advertised a Phage Production QC Technician (permanent, Suresnes, France) to run in-process quality control across the bacteriophage production lifecycle: bacterial and phage titrations, sterility testing and endotoxin measurement un

Plaza Feed & Crop Nutrition has an exclusive agreement with Intralytix to use its bacteriophage products in phage kits for livestock production, pairing phages grouped to target E. coli, Salmonella and Listeria with Plaza's Cecabiotics prob

BiomX announced on December 8, 2025 that it was discontinuing its Phase 2b trial of BX004 in cystic fibrosis patients with chronic Pseudomonas aeruginosa infections, saying the time and resources needed for the alternative dosing strategy r

Cytophage Technologies announced on August 25, 2025 that it received two Letters of No Objection from Health Canada's Food Directorate for its OvaPhage egg-surface and PhageFend food-surface bacteriophage products. According to the company,

iNtRON Biotechnology announced on August 5, 2025 that its IMPA (Intelligent Modular Phage Assembly) phage engineering technology produced a phage carrying a colibactin-degrading protein on its capsid. The company says the engineered phage k

The University of Florida has granted Phageolytix an exclusive worldwide license to multi-indication bacteriophage cocktails developed by researchers in its College of Medicine-Jacksonville (announced July 14, 2025). Phageolytix will manufa

A Future Market Insights press release projects the global bacteriophage market rising from USD 49 million in 2025 to USD 72.4 million by 2035, a 4.0% CAGR. It points to bacteriophage therapy as an alternative to antibiotics and to phage-ba

Cytophage Technologies announced the development of a phage-based vaccine for avian influenza (H5N1). Two candidates that use filamentous bacteriophages to display influenza antigens are entering preclinical validation, where a pilot study

PrecisionPhage raised €1 million from Nordic Science Investment, Genetricum and Unifund and secured €1.2 million in Deep Tech Accelerator funding from Business Finland, a €2.2 million seed round. The company develops bioinformatic tools for

PhageEU, a coalition founded by Proteon Pharmaceuticals (Poland), PTC Technology Center (Germany) and JAFRAL (Slovenia) that represents phages in industry, science and civil society, has registered as a non-profit organisation with its seat